全文获取类型
收费全文 | 1152篇 |
免费 | 66篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 84篇 |
妇产科学 | 26篇 |
基础医学 | 149篇 |
口腔科学 | 13篇 |
临床医学 | 102篇 |
内科学 | 348篇 |
皮肤病学 | 25篇 |
神经病学 | 52篇 |
特种医学 | 62篇 |
外科学 | 140篇 |
综合类 | 36篇 |
预防医学 | 48篇 |
眼科学 | 11篇 |
药学 | 66篇 |
中国医学 | 1篇 |
肿瘤学 | 74篇 |
出版年
2023年 | 3篇 |
2022年 | 7篇 |
2021年 | 25篇 |
2020年 | 11篇 |
2019年 | 25篇 |
2018年 | 21篇 |
2017年 | 14篇 |
2016年 | 21篇 |
2015年 | 27篇 |
2014年 | 35篇 |
2013年 | 40篇 |
2012年 | 58篇 |
2011年 | 60篇 |
2010年 | 53篇 |
2009年 | 48篇 |
2008年 | 66篇 |
2007年 | 57篇 |
2006年 | 70篇 |
2005年 | 71篇 |
2004年 | 37篇 |
2003年 | 39篇 |
2002年 | 31篇 |
2001年 | 37篇 |
2000年 | 39篇 |
1999年 | 32篇 |
1998年 | 51篇 |
1997年 | 32篇 |
1996年 | 22篇 |
1995年 | 18篇 |
1994年 | 22篇 |
1993年 | 17篇 |
1992年 | 10篇 |
1991年 | 21篇 |
1990年 | 10篇 |
1989年 | 12篇 |
1988年 | 10篇 |
1987年 | 10篇 |
1986年 | 12篇 |
1985年 | 18篇 |
1984年 | 6篇 |
1983年 | 8篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 6篇 |
1977年 | 2篇 |
1976年 | 3篇 |
1975年 | 2篇 |
1973年 | 3篇 |
1969年 | 2篇 |
1967年 | 2篇 |
排序方式: 共有1247条查询结果,搜索用时 15 毫秒
1.
Caterina Proto Daniela Romualdi Rosa Maria Cento Rosario S Spada Giuseppina Di Mento Raffaele Ferri Antonio Lanzone 《Gynecological endocrinology》2006,22(4):213-218
BACKGROUND: In the central nervous system, several neuropeptides are believed to be involved in the pathophysiology of Alzheimer's disease (AD). Indeed, previous studies have documented that glucagon-like peptide 1 (GLP-1) possesses neurotropic properties and can reduce amyloid-beta peptide levels in the brain in vivo. Moreover, the concentrations of neuropeptide Y (NPY) seem to be altered in the cerebrospinal fluid of patients with AD and in subjects with major depression. Finally, among the modifications induced by aging, a dysregulation of the ghrelin-growth hormone (GH) system has been reported. METHODS: We investigated the plasma concentrations of these neuropeptides in 14 subjects with AD. Data obtained from these patients were compared with data from an age- and weight-matched healthy group. RESULTS: No significant differences were found between the two groups in relation to plasma levels of GLP-1, NPY, ghrelin and GH. Peripheral NPY concentrations were positively correlated with ghrelin levels in both groups, and with plasma GLP-1 concentration only in controls. CONCLUSION: On the basis of our results, peripheral levels of these neuropeptides seem not to serve as biochemical markers of AD. 相似文献
2.
Albert R. La Spada MD PhD Arthur W. Clark MD 《Brain pathology (Zurich, Switzerland)》1997,7(3):877-880
At the beginning of this decade, the American Association of Neurology decided that the 1990's should be labelled "the decade of the brain" for expected advances in our understanding of neurological disorders and neuroscience. By the end of this decade, clinicians and researchers who work in the field of inherited neurological disorders might well remember the 1990's as "the decade of the trinucleotide repeat". At the time of writing this introduction, eleven inherited neurological disorders have been found to be caused by expansions of trinucleotide repeats, and a twelfth trinucleotide repeat expansion mutation has been identified (6), although the gene containing this mutant triplet repeat has not been cloned to our knowledge (Table 1). 相似文献
3.
M Giovannini E Spada M P Broccoli 《Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde》1990,201(1):1-4
We examined 57 patients who showed conjunctivitis suspected of allergic pathogenesis with skin radioallergosorbent (RAST) and conjunctival provocation tests (CPT). Our aim was to define statistical correlations between those tests and their exact values for the right diagnosis. Our data show that CPT is more sensitive than skin tests or RAST to ascertain the origin of conjunctivitis. 相似文献
4.
5.
6.
M. Spada W. Petz A. Bertani S. Riva A. Sonzogni M. Giovannelli E. Torri G. Torre M. Colledan B. Gridelli 《American journal of transplantation》2006,6(8):1913-1921
Avoidance of corticosteroids could be beneficial after pediatric liver transplantation (LTx). To test this hypothesis, we performed a randomized prospective study to compare immunosuppression with tacrolimus (TAC) and steroids versus TAC and basiliximab (BAS) after pediatric LTx. Seventy-two patients were recruited, 36 receiving TAC and steroids and 36 TAC and BAS. The primary endpoint was the occurrence of the first rejection episode. Secondary endpoints were the cumulative incidence and severity of rejection, patient and graft survival, and incidence of adverse events. Overall 1-year patient and graft survival rates were 91.4% and 85.5% in the steroid group, and 88.6% and 80% in the BAS group (p = NS). Patients free from rejection were 87.7% in the BAS group and 67.7% in the steroid group (p = 0.036). The use of BAS was associated with a 63.6% reduction in incidence of acute rejection episodes. Overall incidence of infection was 72.3% in the steroid group and 50% in the BAS group (p = 0.035). We conclude that the combination of TAC with BAS is an alternative to TAC and steroid immunosuppression in pediatric LTx, which allows for a significant reduction in the incidence of acute rejection and infectious complications. 相似文献
7.
8.
Thomas Patrick S. Jr; Fraley Gregory S.; Damian Vincent; Woodke Lillie B.; Zapata Francisco; Sopher Bryce L.; Plymate Stephen R.; La Spada Albert R. 《Human molecular genetics》2006,15(19):2972
Human Molecular 相似文献
9.
AP de Moraes† ÉÂG de Arruda† MAV Vitoriano† MO de Moraes Filho‡ FÂF Bezerra‡ E de Magalhães Holanda§ MEA de Moraes‡ 《Journal of the European Academy of Dermatology and Venereology》2007,21(5):596-601
BACKGROUND: Seborrhoeic dermatitis (SD) is a common dermatosis in human immunodeficiency virus (HIV)-positive patients, many of whom do not respond satisfactorily to conventional topical treatments such as corticosteroids and antifungals. OBJECTIVE: A pilot study to investigate the efficacy and tolerability of pimecrolimus cream 1% in HIV-positive patients with facial SD. METHODS: In a single-centre study, 21 HIV-infected patients with mild to severe SD were treated twice daily with pimecrolimus cream 1% for 14 days. Thereafter, treatment was discontinued and patients followed up for 5 weeks. Skin involvement at baseline and on days 7, 14, 21, 35 and 49 was assessed using a four-point clinical score and digital photography. MAIN OUTCOME MEASURES: Efficacy and safety of pimecrolimus cream 1% treatment and incidence of relapse in the follow-up phase. Results Marked improvement was seen in clinical parameters at day 7, with >or= 90% patients clear of symptoms at day 14. Relapse was observed at day 35 but signs were milder than at baseline. All patients responded to therapy, despite their immunological status. Pimecrolimus did not alter CD4(+) and CD8(+) T-cell counts or viral load during the treatment period. CONCLUSION: Pimecrolimus cream represents a new, effective therapeutic option for facial SD in HIV patients. 相似文献
10.